Press Releases April 30, 2026 08:00 AM

GrowGeneration Announces First Quarter 2026 Earnings Release Conference Call for May 12, 2026

GrowGeneration Announces Date for Q1 2026 Earnings Release and Conference Call

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
GRWG

GrowGeneration Corp., a leading supplier of specialty products for controlled environment agriculture and commercial cultivation, will release its Q1 2026 financial results on May 12, 2026, accompanied by a live earnings call. The company highlighted its diverse product offerings and proprietary brands, as well as its online and wholesale business operations.

GrowGeneration Announces First Quarter 2026 Earnings Release Conference Call for May 12, 2026
GRWG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • GrowGeneration provides specialty products to controlled environment agriculture, commercial cultivation, and retail garden centers sectors.
  • The company operates an online superstore and a wholesale business, expanding its market reach.
  • Q1 2026 earnings release and conference call scheduled for May 12, 2026, providing insights into the company's financial performance.

DENVEVER, Colo., April 30, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the first quarter ended March 31, 2026, on Tuesday, May 12, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET.

To participate in the call, please dial 1-(888)-699-1199 (domestic) or 1-(416)-945-7677 (international). The conference code is 98549. A recording of the webcast can be accessed here or in the Investor Relations section of the GrowGeneration website at: https://ir.growgeneration.com.

A replay of the webcast will be available approximately two hours after the conclusion of the call and will remain available for approximately 90 calendar days.

About GrowGeneration Corp:
GrowGen is one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Char Coir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. The Company also operates an online superstore for cultivators at growgeneration.com, as well as a wholesale business for resellers, and a benching, racking, and storage solutions business, MMI Storage Solutions.

To be added to the GrowGeneration email distribution list, please email GrowGen@kcsa.com with GRWG in the subject line.

Investor Relations:
KCSA Strategic Communications
Philip Carlson, Managing Director
T: 212-896-1233
GrowGen@KCSA.com


Risks

  • Financial performance uncertainty related to Q1 2026 results which may impact investor sentiment.
  • Market demand fluctuations for controlled environment agriculture and cultivation products could affect revenue.
  • Competition within the agriculture supply and retail sectors may pressure margins and growth prospects.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026